Drug Profile


Alternative Names: GG 211; GI 147211; GI 147211C; GW 211; Lurtotecan dihydrochloride

Latest Information Update: 03 Dec 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Developer GlaxoSmithKline; Nonindustrial source
  • Class Alkaloids; Antineoplastics; Camptothecins
  • Mechanism of Action DNA topoisomerase I inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer; Ovarian cancer

Most Recent Events

  • 03 Dec 1999 Discontinued-II for Cancer in Netherlands (Infusion)
  • 03 Dec 1999 Discontinued-II for Cancer in United Kingdom (Infusion)
  • 03 Dec 1999 Discontinued-II for Cancer in USA (Infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top